Latest News in the pharma Industry

All

Merck Ventures creates new immuno-oncology company iOnctura

Merck Ventures creates new immuno-oncology company iOnctura

20 Jun 2017

iOnctura is set up to develop a pipeline of assets targeting immunosuppression in the tumour microenvironment.

Read more 
FDA accepts Amgen's sBLA to expand indication for Xgeva to include multiple myeloma patients

FDA accepts Amgen's sBLA to expand indication for Xgeva to include multiple myeloma patients

19 Jun 2017

Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumours and is the number one prescribed agent by oncologists for this indication in the US.

Read more 
J&J completes acquisition of Actelion

J&J completes acquisition of Actelion

19 Jun 2017

Actelion will now become part of the Janssen Pharmaceutical Companies of J&J.

Read more 
Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases

Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases

19 Jun 2017

Sandoz now has four biosimilars approved in Europe - more than any other company.

Read more